Refractory ARDS ECMO — FRCA Final MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — ECMO referral
EOLIA trial: VV-ECMO for severe refractory ARDS. Refer early. iNO improves oxygenation transiently but no mortality benefit. HFOV showed harm (OSCILLATE). ECMO is the appropriate escalation for refractory hypoxaemia.
Reference: ICS/BTS – 2023 – ARDS guidelines; ELSO – 2024